Tag: AHA 2023
AHA 2023: RCE Technologies wins Health Tech competition
RCE Technologies, the developer of a non-invasive, instant measurement of cardiac proteins was selected as the winner of the annual Health Tech competition at...
ARTESIA shows reduced rate of stroke and embolism in sub-clinical AF...
Use of apixaban in patients with sub-clinical atrial fibrillation (AF) resulted in a lower risk of stroke or systemic embolism than aspirin, but a...
SELECT trial shows cardiovascular risk reduction in non-diabetics taking semaglutide
Results of the SELECT clinical trial, presented at the American Heart Association’s 2023 Scientific Sessions (11–13 November, Philadelphia, USA), have shown that overweight or...